{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:52:09Z","timestamp":1787003529351,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/15\/20\/31335"],"award-info":[{"award-number":["FS\/15\/20\/31335"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["SP\/15\/7\/31561"],"award-info":[{"award-number":["SP\/15\/7\/31561"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Blood vessels in the body are lined with endothelial cells which have vital roles in numerous physiological and pathological processes. Collagens are major constituents of the extracellular matrix, and many adherent cells express several collagen-binding adhesion receptors. Here, we study the endothelium\u2013collagen interactions mediated by the collagen-binding integrins, \u03b11\u03b21, \u03b12\u03b21, \u03b110\u03b21 and \u03b111\u03b21 expressed in human umbilical vein endothelial cells (HUVECs). Using qPCR, we found expression of the \u03b110 transcript of the chondrocyte integrin, \u03b110\u03b21, along with the more abundant \u03b12, and low-level expression of \u03b11. The \u03b111 transcript was not detected. Inhibition or siRNA knockdown of the \u03b12-subunit resulted in impaired HUVEC adhesion, spreading and migration on collagen-coated surfaces, whereas inhibition or siRNA knockdown of \u03b11 had no effect on these processes. In tube formation assays, inhibition of either \u03b11 or \u03b12 subunits impaired the network complexity, whereas siRNA knockdown of these integrins had no such effect. Knockdown of \u03b110 had no effect on cell spreading, migration or tube formation in these conditions. Overall, our results indicate that the collagen-binding integrins, \u03b11\u03b21 and \u03b12\u03b21 play a central role in endothelial cell motility and self-organisation.<\/jats:p>","DOI":"10.1038\/s41598-022-25937-1","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T05:05:49Z","timestamp":1670994349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effects of inhibition and siRNA knockdown of collagen-binding integrins on human umbilical vein endothelial cell migration and tube formation"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-119X","authenticated-orcid":false,"given":"Emma J.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir W.","family":"Hamaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.-K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel M.","family":"Malcor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-8808","authenticated-orcid":false,"given":"Richard W.","family":"Farndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"10","key":"25937_CR1","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran, P. et al. The vascular endothelium and human diseases. Int. J. Biol. Sci. 9(10), 1057\u20131069 (2013).","journal-title":"Int. J. Biol. Sci."},{"key":"25937_CR2","first-page":"1548","volume-title":"Molecular Biology of the Cell","author":"B Alberts","year":"2002","unstructured":"Alberts, B. Molecular Biology of the Cell 4th edn, 1548 (Garland Science, 2002).","edition":"4"},{"issue":"6","key":"25937_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/1479164113500680","volume":"10","author":"AC Roberts","year":"2013","unstructured":"Roberts, A. C. & Porter, K. E. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diabetes Vasc. Dis. Res. 10(6), 472\u2013482 (2013).","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"10","key":"25937_CR4","first-page":"3527","volume":"91","author":"DB Cines","year":"1998","unstructured":"Cines, D. B. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91(10), 3527\u20133561 (1998).","journal-title":"Blood"},{"issue":"8","key":"25937_CR5","doi-asserted-by":"publisher","first-page":"a005090","DOI":"10.1101\/cshperspect.a005090","volume":"3","author":"DR Senger","year":"2011","unstructured":"Senger, D. R. & Davis, G. E. Angiogenesis. Cold Spring Harb. Perspect. Biol. 3(8), a005090 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"25937_CR6","doi-asserted-by":"publisher","first-page":"756078","DOI":"10.1155\/2014\/756078","volume":"2014","author":"A Neve","year":"2014","unstructured":"Neve, A. et al. Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed. Res. Int. 2014, 756078 (2014).","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"25937_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/wsbm.7","volume":"1","author":"A Pozzi","year":"2009","unstructured":"Pozzi, A. & Zent, R. Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products. Wiley Interdiscip. Rev. Syst. Biol. Med. 1(2), 254\u2013272 (2009).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"1","key":"25937_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","volume":"339","author":"M Barczyk","year":"2010","unstructured":"Barczyk, M., Carracedo, S. & Gullberg, D. Integrins. Cell Tissue Res. 339(1), 269\u2013280 (2010).","journal-title":"Cell Tissue Res."},{"issue":"6","key":"25937_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbagen.2009.03.007","volume":"1790","author":"CG Gahmberg","year":"2009","unstructured":"Gahmberg, C. G. et al. Regulation of integrin activity and signalling. Biochim. Biophys. Acta 1790(6), 431\u2013444 (2009).","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"25937_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada, Y., Ye, X. & Simon, S. The integrins. Genome Biol. 8(5), 215 (2007).","journal-title":"Genome Biol."},{"key":"25937_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.cellbio.21.090704.151217","volume":"21","author":"MA Arnaout","year":"2005","unstructured":"Arnaout, M. A., Mahalingam, B. & Xiong, J. P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381\u2013410 (2005).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"25937_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/CS20130412","volume":"127","author":"M Alique","year":"2014","unstructured":"Alique, M. et al. Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation. Clin. Sci. (Lond.) 127(1), 19\u201331 (2014).","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"25937_CR13","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1083\/jcb.110.6.2175","volume":"110","author":"DE Hall","year":"1990","unstructured":"Hall, D. E. et al. The alpha 1\/beta 1 and alpha 6\/beta 1 integrin heterodimers mediate cell attachment to distinct sites on laminin. J. Cell Biol. 110(6), 2175\u20132184 (1990).","journal-title":"J. Cell Biol."},{"issue":"24","key":"25937_CR14","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.1073\/pnas.86.24.9906","volume":"86","author":"MJ Elices","year":"1989","unstructured":"Elices, M. J. & Hemler, M. E. The human integrin VLA-2 is a collagen receptor on some cells and a collagen\/laminin receptor on others. Proc. Natl. Acad. Sci. U.S.A. 86(24), 9906\u20139910 (1989).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3\u20134","key":"25937_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/lrb.2008.1011","volume":"6","author":"B Garmy-Susini","year":"2008","unstructured":"Garmy-Susini, B. & Varner, J. A. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat. Res. Biol. 6(3\u20134), 155\u2013163 (2008).","journal-title":"Lymphat. Res. Biol."},{"issue":"25","key":"25937_CR16","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1073\/pnas.94.25.13612","volume":"94","author":"DR Senger","year":"1997","unstructured":"Senger, D. R. et al. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. U.S.A. 94(25), 13612\u201313617 (1997).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"25937_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2353\/ajpath.2009.090234","volume":"175","author":"JD San Antonio","year":"2009","unstructured":"San Antonio, J. D. et al. A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis. Am. J. Pathol. 175(3), 1338\u20131347 (2009).","journal-title":"Am. J. Pathol."},{"key":"25937_CR18","doi-asserted-by":"publisher","first-page":"125278","DOI":"10.1155\/2012\/125278","volume":"2012","author":"S Niland","year":"2012","unstructured":"Niland, S. & Eble, J. A. Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J. Oncol. 2012, 125278 (2012).","journal-title":"J. Oncol."},{"issue":"4","key":"25937_CR19","first-page":"575","volume":"71","author":"GC Haralabopoulos","year":"1994","unstructured":"Haralabopoulos, G. C. et al. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab. Investig. 71(4), 575\u2013582 (1994).","journal-title":"Lab. Investig."},{"issue":"1","key":"25937_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0002-9440(10)64363-5","volume":"160","author":"DR Senger","year":"2002","unstructured":"Senger, D. R. et al. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160(1), 195\u2013204 (2002).","journal-title":"Am. J. Pathol."},{"issue":"4","key":"25937_CR21","first-page":"851","volume":"6","author":"TV Byzova","year":"2000","unstructured":"Byzova, T. V. et al. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins. Mol. Cell 6(4), 851\u2013860 (2000).","journal-title":"Mol. Cell"},{"issue":"22","key":"25937_CR22","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1074\/jbc.270.22.13548","volume":"270","author":"T Riikonen","year":"1995","unstructured":"Riikonen, T. et al. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J. Biol. Chem. 270(22), 13548\u201313552 (1995).","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"25937_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1242\/jcs.112.3.263","volume":"112","author":"H Gardner","year":"1999","unstructured":"Gardner, H. et al. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J. Cell Sci. 112(Pt 3), 263\u2013272 (1999).","journal-title":"J. Cell Sci."},{"issue":"1","key":"25937_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2005.08.003","volume":"1746","author":"MC Ronziere","year":"2005","unstructured":"Ronziere, M. C. et al. Integrin alpha1beta1 mediates collagen induction of MMP-13 expression in MC615 chondrocytes. Biochim. Biophys. Acta 1746(1), 55\u201364 (2005).","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"25937_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/cancers11040587","volume":"11","author":"M Munksgaard Thoren","year":"2019","unstructured":"Munksgaard Thoren, M. et al. Integrin alpha10, a novel therapeutic target in glioblastoma, regulates cell migration, proliferation, and survival. Cancers (Basel) 11(4), 587 (2019).","journal-title":"Cancers (Basel)"},{"issue":"3\u20134","key":"25937_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18632\/oncoscience.350","volume":"4","author":"T Okada","year":"2017","unstructured":"Okada, T. & Singer, S. Integrin-alpha10 drives tumorigenesis in sarcoma. Oncoscience 4(3\u20134), 31\u201332 (2017).","journal-title":"Oncoscience"},{"issue":"5","key":"25937_CR27","first-page":"373","volume":"29","author":"AK Wenke","year":"2007","unstructured":"Wenke, A. K. et al. Expression of integrin alpha10 is induced in malignant melanoma. Cell Oncol. 29(5), 373\u2013386 (2007).","journal-title":"Cell Oncol."},{"issue":"4","key":"25937_CR28","first-page":"653","volume":"129","author":"C Zeltz","year":"2016","unstructured":"Zeltz, C. & Gullberg, D. The integrin-collagen connection\u2014A glue for tissue repair? J. Cell Sci. 129(4), 653\u2013664 (2016).","journal-title":"J. Cell Sci."},{"key":"25937_CR29","doi-asserted-by":"publisher","first-page":"e42274","DOI":"10.7554\/eLife.42274","volume":"8","author":"B Shen","year":"2019","unstructured":"Shen, B. et al. Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. Elife 8, e42274 (2019).","journal-title":"Elife"},{"issue":"3","key":"25937_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1073\/pnas.0811622106","volume":"106","author":"MW Miller","year":"2009","unstructured":"Miller, M. W. et al. Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proc. Natl. Acad. Sci. U.S.A. 106(3), 719\u2013724 (2009).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"25937_CR31","doi-asserted-by":"publisher","first-page":"115669","DOI":"10.1016\/j.taap.2021.115669","volume":"428","author":"EJ Hunter","year":"2021","unstructured":"Hunter, E. J. et al. Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin. Toxicol. Appl. Pharmacol. 428, 115669 (2021).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"25937_CR32","first-page":"2020","volume":"63","author":"C Marcinkiewicz","year":"2003","unstructured":"Marcinkiewicz, C. et al. Obtustatin: A potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res. 63(9), 2020\u20132023 (2003).","journal-title":"Cancer Res."},{"issue":"9","key":"25937_CR33","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/ijc.23777","volume":"123","author":"MC Brown","year":"2008","unstructured":"Brown, M. C. et al. Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth. Int. J. Cancer 123(9), 2195\u20132203 (2008).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"25937_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1182\/blood.V74.1.182.182","volume":"74","author":"BS Coller","year":"1989","unstructured":"Coller, B. S. et al. Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa\/IIa and an indirect interaction with platelet GPIIb\/IIIa mediated by adhesive proteins. Blood 74(1), 182\u2013192 (1989).","journal-title":"Blood"},{"issue":"Pt 2","key":"25937_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/BST0360241","volume":"36","author":"RW Farndale","year":"2008","unstructured":"Farndale, R. W. et al. Cell-collagen interactions: The use of peptide toolkits to investigate collagen-receptor interactions. Biochem. Soc. Trans. 36(Pt 2), 241\u2013250 (2008).","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"25937_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1006\/dbio.2001.0363","volume":"237","author":"CF Tiger","year":"2001","unstructured":"Tiger, C. F. et al. Alpha11beta1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev. Biol. 237(1), 116\u2013129 (2001).","journal-title":"Dev. Biol."},{"key":"25937_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biomaterials.2016.01.044","volume":"85","author":"JD Malcor","year":"2016","unstructured":"Malcor, J. D. et al. The synthesis and coupling of photoreactive collagen-based peptides to restore integrin reactivity to an inert substrate, chemically-crosslinked collagen. Biomaterials 85, 65\u201377 (2016).","journal-title":"Biomaterials"},{"key":"25937_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-0500-6-46","volume":"6","author":"R Wei","year":"2013","unstructured":"Wei, R., Stewart, E. A. & Amoaku, W. M. Suitability of endogenous reference genes for gene expression studies with human intraocular endothelial cells. BMC Res. Notes 6, 46 (2013).","journal-title":"BMC Res. Notes"},{"issue":"1","key":"25937_CR39","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1038\/s41598-020-67289-8","volume":"10","author":"G Carpentier","year":"2020","unstructured":"Carpentier, G. et al. Angiogenesis Analyzer for ImageJ\u2014A comparative morphometric analysis of \u201cendothelial tube formation assay\u201d and \u201cfibrin bead assay\u201d. Sci. Rep. 10(1), 11568 (2020).","journal-title":"Sci. Rep."},{"issue":"9","key":"25937_CR40","doi-asserted-by":"publisher","first-page":"a005074","DOI":"10.1101\/cshperspect.a005074","volume":"3","author":"A Huttenlocher","year":"2011","unstructured":"Huttenlocher, A. & Horwitz, A. R. Integrins in cell migration. Cold Spring Harb. Perspect. Biol. 3(9), a005074 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"25937_CR41","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1091\/mbc.e07-06-0582","volume":"18","author":"WH Guo","year":"2007","unstructured":"Guo, W. H. & Wang, Y. L. Retrograde fluxes of focal adhesion proteins in response to cell migration and mechanical signals. Mol. Biol. Cell 18(11), 4519\u20134527 (2007).","journal-title":"Mol. Biol. Cell"},{"issue":"5651","key":"25937_CR42","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley, A. J. et al. Cell migration: Integrating signals from front to back. Science 302(5651), 1704\u20131709 (2003).","journal-title":"Science"},{"issue":"4","key":"25937_CR43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood-2007-06-094680","volume":"111","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z. et al. Alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 111(4), 1980\u20131988 (2008).","journal-title":"Blood"},{"issue":"2","key":"25937_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.jid.5700546","volume":"127","author":"MC Zweers","year":"2007","unstructured":"Zweers, M. C. et al. Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J. Investig. Dermatol. 127(2), 467\u2013478 (2007).","journal-title":"J. Investig. Dermatol."},{"issue":"1","key":"25937_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9440(10)64185-5","volume":"161","author":"J Chen","year":"2002","unstructured":"Chen, J. et al. The alpha(2) integrin subunit-deficient mouse: A multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am. J. Pathol. 161(1), 337\u2013344 (2002).","journal-title":"Am. J. Pathol."},{"issue":"29","key":"25937_CR46","doi-asserted-by":"publisher","first-page":"25947","DOI":"10.1074\/jbc.M111.243626","volume":"286","author":"A Goyal","year":"2011","unstructured":"Goyal, A. et al. Endorepellin, the angiostatic module of perlecan, interacts with both the alpha2beta1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): A dual receptor antagonism. J. Biol. Chem. 286(29), 25947\u201325962 (2011).","journal-title":"J. Biol. Chem."},{"issue":"22","key":"25937_CR47","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jnci\/djj441","volume":"98","author":"G Bix","year":"2006","unstructured":"Bix, G. et al. Endorepellin in vivo: Targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl. Cancer Inst. 98(22), 1634\u20131646 (2006).","journal-title":"J Natl. Cancer Inst."},{"issue":"18","key":"25937_CR48","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/j.yexcr.2008.08.011","volume":"314","author":"P Nyberg","year":"2008","unstructured":"Nyberg, P. et al. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor. Exp. Cell Res. 314(18), 3292\u20133305 (2008).","journal-title":"Exp. Cell Res."},{"issue":"1","key":"25937_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/02713680903374208","volume":"35","author":"CS Boosani","year":"2010","unstructured":"Boosani, C. S. et al. Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cells. Curr. Eye Res. 35(1), 45\u201355 (2010).","journal-title":"Curr. Eye Res."},{"issue":"5","key":"25937_CR50","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1073\/pnas.040378497","volume":"97","author":"A Pozzi","year":"2000","unstructured":"Pozzi, A. et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. U.S.A. 97(5), 2202\u20132207 (2000).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 6","key":"25937_CR51","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1242\/jcs.108.6.2321","volume":"108","author":"CM DiPersio","year":"1995","unstructured":"DiPersio, C. M., Shah, S. & Hynes, R. O. Alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J. Cell Sci. 108(Pt 6), 2321\u20132336 (1995).","journal-title":"J. Cell Sci."},{"issue":"45","key":"25937_CR52","doi-asserted-by":"publisher","first-page":"28512","DOI":"10.1074\/jbc.272.45.28512","volume":"272","author":"J Emsley","year":"1997","unstructured":"Emsley, J. et al. Crystal structure of the I domain from integrin alpha2beta1. J. Biol. Chem. 272(45), 28512\u201328517 (1997).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"25937_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0092-8674(00)80622-4","volume":"101","author":"J Emsley","year":"2000","unstructured":"Emsley, J. et al. Structural basis of collagen recognition by integrin alpha2beta1. Cell 101(1), 47\u201356 (2000).","journal-title":"Cell"},{"issue":"1","key":"25937_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2050-7771-1-16","volume":"1","author":"S Boudjadi","year":"2013","unstructured":"Boudjadi, S., Carrier, J. C. & Beaulieu, J. F. Integrin alpha1 subunit is up-regulated in colorectal cancer. Biomark. Res. 1(1), 16 (2013).","journal-title":"Biomark. Res."},{"issue":"8","key":"25937_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cancers9080096","volume":"9","author":"S Boudjadi","year":"2017","unstructured":"Boudjadi, S. et al. Involvement of the integrin alpha1beta1 in the progression of colorectal cancer. Cancers (Basel) 9(8), 96 (2017).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"25937_CR56","first-page":"1307","volume":"31","author":"S Ibaragi","year":"2011","unstructured":"Ibaragi, S. et al. Induction of MMP-13 expression in bone-metastasizing cancer cells by type I collagen through integrin alpha1beta1 and alpha2beta1-p38 MAPK signaling. Anticancer Res. 31(4), 1307\u20131313 (2011).","journal-title":"Anticancer Res."},{"issue":"5","key":"25937_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10585-012-9561-6","volume":"30","author":"JL Sottnik","year":"2013","unstructured":"Sottnik, J. L. et al. Integrin alpha2beta 1 (\u03b12\u03b21) promotes prostate cancer skeletal metastasis. Clin. Exp. Metastasis 30(5), 569\u2013578 (2013).","journal-title":"Clin. Exp. Metastasis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25937-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T06:32:47Z","timestamp":1670999567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25937-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25937"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25937-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.W.F. is Chief Scientific Officer of CambCol Laboratories Ltd, Ely, Cambridgeshire, UK. The other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21601"}}